Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Neogen's annualizedGross Profit for the quarter that ended in Aug. 2024 was $419.7 Mil.
Neogen's average Total Assets over the quarter that ended in Aug. 2024 was $4,526.0 Mil. Therefore, Neogen's annualized Gross-Profit-to-Asset % for the quarter that ended in Aug. 2024 was 9.27%.
Neogen Gross-Profit-to-Asset % Historical Data
The historical data trend for Neogen's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Neogen's Gross-Profit-to-Asset %
For the Diagnostics & Research subindustry, Neogen's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neogen's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Neogen's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where Neogen's Gross-Profit-to-Asset % falls into.
Neogen Gross-Profit-to-Asset % Calculation
Neogen's annualized Gross-Profit-to-Asset % for the fiscal year that ended in May. 2024 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Aug. 2024) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
Neogen Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of Neogen's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NEOG has been successfully added to your 